English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NA /

BNT211-01

Phase I/Iia, First-In-Human (FIH), Open-Label, Dose Escalation Trial With Expansion Cohorts To Evaluate Safety And Preliminary Efficacy Of CLDN6 CAR-T +/- CLDN6 RNA-LPX In Patients With CLDN6-Positive Relapsed Or Refractory Advanced Solid Tumors

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: